ACCELERON PHARMA INC 4
4 · ACCELERON PHARMA INC · Filed Sep 26, 2013
Insider Transaction Report
Form 4
Maniatis Tom
Director
Transactions
- Conversion
Common Stock
2013-09-24+25,108→ 250,108 total - Conversion
Common Stock
2013-09-24+9,261→ 259,369 total - Conversion
Common Stock
2013-09-24+5,348→ 264,717 total - Conversion
Series A Convertible Preferred Stock
2013-09-24−25,108→ 0 total→ Common Stock (25,108 underlying) - Conversion
Common Stock
2013-09-24+714→ 265,431 total - Conversion
Series D Convertible Preferred Stock
2013-09-24−714→ 0 total→ Common Stock (714 underlying) - Conversion
Series B Convertible Preferred Stock
2013-09-24−9,261→ 0 total→ Common Stock (9,261 underlying) - Conversion
Series C Convertible Preferred Stock
2013-09-24−5,348→ 0 total→ Common Stock (5,348 underlying)
Footnotes (1)
- [F1]Upon closing of the Issuer's initial public offering, each share of Series A, B, C and D Convertible Preferred Stock automatically converted into one share of Common Stock without payment of further consideration. The shares had no expiration date.